JPY 1091.0
(-0.09%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 66.35 Million JPY | 286.49% |
2022 | -35.57 Million JPY | -139.88% |
2021 | 89.21 Million JPY | 34.8% |
2020 | 66.18 Million JPY | -25.64% |
2019 | 89 Million JPY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 91 Million JPY | 19.68% |
2023 Q2 | 4.4 Million JPY | 122.4% |
2023 Q4 | 76.03 Million JPY | 1261.96% |
2023 Q3 | 5.58 Million JPY | 26.68% |
2023 FY | 66.35 Million JPY | 286.49% |
2023 Q1 | -19.67 Million JPY | -155.18% |
2022 Q3 | -25 Million JPY | -16.66% |
2022 FY | -35.57 Million JPY | -139.88% |
2022 Q4 | 35.65 Million JPY | 242.62% |
2022 Q2 | -21.43 Million JPY | 0.0% |
2021 FY | 89.21 Million JPY | 34.8% |
2020 FY | 66.18 Million JPY | -25.64% |
2019 FY | 89 Million JPY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 14.28 Billion JPY | 99.535% |
Cosmo Bio Company,Limited | 3.25 Billion JPY | 97.958% |
H.U. Group Holdings, Inc. | 63.23 Billion JPY | 99.895% |
FALCO HOLDINGS Co., Ltd. | 12.71 Billion JPY | 99.478% |
BML, Inc. | 45.62 Billion JPY | 99.855% |
Human Metabolome Technologies, Inc. | 869.33 Million JPY | 92.367% |
Precision System Science Co., Ltd. | 950.37 Million JPY | 93.018% |